A RANDOMIZED DOUBLE-BLIND PARALLELL GROUP CLINICAL STUDY OF XENETIX 300 VERSUS VISIPAQUE 270 IN MULTISLICE CT PEDIATRIC INDICATIONS

Update Il y a 4 ans
Reference: EUCTR2005-000664-51

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To demonstrate the equivalence of Xenetix 300 and Visipaque 270 in terms of renal tolerance when injected for MSCT in pediatric indications


Inclusion criteria

  • Patients requiring MSCT with contrast medium injection for diagnosis